Vaccine-induced Th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3533-3544

  Lindenstrøm, Thomas ^a   Woodworth, Joshua ^a   Dietrich, Jes ^a   Aagaard, Claus ^a   Andersen, Peter ^a   Agger, Else Marie ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATIONIC LIPOSOME ADJUVANT CAF01; IMMUNOLOGICAL ADJUVANT; UNCLASSIFIED DRUG; VACCINE;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL MOTILITY; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOPHENOTYPING; LONG TERM CARE; LUNG TUBERCULOSIS; LYMPH NODE; MEMORY T LYMPHOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TREATMENT OUTCOME; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL PROTEINS; CYTOKINES; FEMALE; IMMUNOLOGIC MEMORY; LYMPH NODES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TH17 CELLS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84867591886     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00550-12     Document Type: Article

References (58)

1. Aagaard C, et al. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17:189-194.
2. Acosta-Rodriguez EV, et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-646.
3. Agger EM, et al. 2008. Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS One 3:e3116. doi:10.1371/ journal.pone.0003116.
4. Aujla SJ, et al. 2008. IL-22 mediates mucosal host defense against Gramnegative bacterial pneumonia. Nat. Med. 14:275-281.
5. Chen K, et al. 2011. Th17 cells mediate clade-specific, serotypeindependent mucosal immunity. Immunity 35:997-1009.
6. Chen XC, et al. 2010. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4 T cells. Am. J. Respir. Crit. Care Med. 181:734-742.
7. Cox CA, et al. 2008. Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J. Immunol. 180:7414-7422.
8. Croxford AL, Kurschus FC, Waisman A. 2009. Cutting edge: an IL-17FCre(EYFP) reporter mouse allows fate mapping of Th17 cells. J. Immunol. 182:1237-1241.
9. Cruz A, et al. 2010. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J. Exp. Med. 207:1609-1616.
10. Cruz A, et al. 2006. Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177:1416-1420.
11. Datta SK, et al. 2010. Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc. Natl. Acad. Sci. U. S. A. 107:10638-10643.
12. Davidsen J, et al. 2005. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6=-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. Biochim. Biophys. Acta Biomembr. 1718: 22-31.
13. Dileepan T, et al. 2011. Robust antigen specific Th17 T cell response to group A streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog. 7:e1002252. doi:10.1371/journal.ppat.1002252.
14. Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G. 2010. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One 5:e15531. doi: 10.1371/journal.pone.0015531.
15. Dong C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337-348.
16. Duffy D, et al. 2009. Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection. PLoS One 4:e8272. doi:10.1371/journal.pone.0008272.
17. Elvang T, et al. 2009. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS One 4:e5139. doi:10.1371/ journal.pone.0005139.
18. Ghannam S, et al. 2011. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions. J. Immunol. 186:1411-1420.
19. Goldberg M, et al. 2009. Synergism between tumor necrosis factor β and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes. Mol. Immunol. 46:1854-1859.
20. Harrington LE, et al. 2005. Interleukin 17-producing CD4 effect or T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
21. Higgins SC, Jarnicki AG, Lavelle EC, Mills KHG. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177:7980-7989.
22. Hirota K, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12:255-263.
23. Huang WT, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
24. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377.
25. Khader SA, et al. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175:788-795.
26. H17 cells are long-lived effector memory cells. Sci. Transl. Med. 3:104ra100795. doi:10.1126/scitranslmed.3002949.
27. Kurschus FC, et al. 2010. Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 40:3336-3346.
28. Lee YK, et al. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107.
29. Lexberg MH, et al. 2010. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur. J. Immunol. 40:3017-3027.
30. Lexberg MH, et al. 2008. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 38:2654-2664.
31. Lin JS, Kummer LW, Szaba FM, Smiley ST. 2011. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J. Immunol. 186:1675-1684.
32. Lindenstrøm T, et al. 2009. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol. 182:8047-8055.
33. Mangan PR, et al. 2006. Transforming growth factor-β induces development of the TH17 lineage. Nature 441:231-234.
34. Mehling M, et al. 2010. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology 75:403-410.
35. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
36. Mukasa R, et al. 2010. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32:616-627.
37. Muranski P, et al. 2011. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35:972-985.
38. Nurieva R, Yang XXO, Chung Y, Dong C. 2009. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J. Immunol. 182:2565-2568.
39. Olsen AW, Theisen M, Christensen D, Follmann F, Andersen P. 2010. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model. PLoS One 5:e10768. doi:10.1371/journal.pone.0010768.
40. Olsen AW, van Pinxteren LAH, Okkels LM, Rasmussen PB, Andersen P. 2001. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect. Immun. 69:2773-2778.
41. Park H, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
42. Pepper M, et al. 2010. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11:83-89.
43. Qiao D, et al. 2011. ESAT-6-and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection. Scand. J. Immunol. 73:330-337.
44. Ruddy MJ, et al. 2004. Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer-binding protein family members. J. Biol. Chem. 279:2559-2567.
45. Schoenen H, et al. 2010. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 184:2756-2760.
46. Scriba TJ, et al. 2008. Distinct, specific IL-17-and IL-22-producing CD4 T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180:1962-1970.
47. Sellge G, et al. 2010. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J. Immunol. 184:2076-2085.
48. Steinfelder S, et al. 2011. Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. Blood 117:2839-2846.
49. van Dissel JT, et al. 2010. Ag85B-ESAT-6 adjuvanted with IC31 (R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers. Vaccine 28:3571-3581.
50. van Dissel JT, et al. 2011. Ag85B-ESAT-6 adjuvanted with IC31 (R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine 29:2100-2109.
51. Wei G, et al. 2009. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4 T cells. Immunity 30:155-167.
52. Werninghaus K, et al. 2009. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation. J. Exp. Med. 206: 89-97.
53. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. 2011. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One 6:e17204. doi:10.1371/journal.pone.0017204.
54. Wozniak TM, Saunders BM, Ryan AA, Britton WJ. 2010. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect. Immun. 78:4187-4194.
55. Yang XXO, et al. 2008. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity 28:29-39.
56. Ye P, et al. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25:335-340.
57. Yoshida YO, et al. 2010. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184: 4414-4422.
58. Yu H, et al. 2010. Chlamydia muridarum T cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-γ)/tumor necrosis factor α and IFN-γ/interleukin-17 double-positive CD4 T cells. Infect. Immun. 78:2272-2282.